In addition, a 16% higher risk of amphetamine usage (OR, 1.2) was observed among cases compared to controls
Cytochrome P450 enzymes (CYPs) mediate the phase I metabolic pathway of BBR in the liver (Guo et al., 2011a)
reports compensation for consulting and/or SAB membership from Honeycomb Biotechnologies, Cellarity, Ochre Bio, Bio-Rad Laboratories, Relation Therapeutics, IntrECate Biotherapeutics, Parabalis Medicines, Quotient Therapeutics, Passkey Therapeutics, Danaher, Senda Biosciences and Dahlia Biosciences unrelated to this work
Grober, Magnesium and Drugs, International Journal of Molecular Sciences, vol
Regular retesting intervals allow for treatment optimization and ensure that therapeutic blood levels are maintained over time